Stockscreener 앱 받기
66.75
2.18%
-1.49
시간 외 거래:
66.71
-0.04
-0.06%
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
Insider Selling: Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells 2,133 Shares of Stock - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Elizabeth Yeu Lin Sells 375 Shares - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Jeffrey Farrow Sells 2,111 Shares - MarketBeat
Insider Selling: Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells 2,186 Shares of Stock - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) CEO Bobak Azamian Sells 11,667 Shares - MarketBeat
Bobak Azamian Sells 10,972 Shares of Tarsus Pharmaceuticals (NASDAQ:TARS) Stock - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) CEO Sells $801,588.00 in Stock - MarketBeat
Bryan Wahl Sells 4,084 Shares of Tarsus Pharmaceuticals (NASDAQ:TARS) Stock - MarketBeat
Tarsus Pharma CHRO Whitfield sells $839k in shares By Investing.com - Investing.com South Africa
Azamian, Tarsus Pharmaceuticals CEO, sells $2.36m in stock - Investing.com
Tarsus Pharma CMO Lin sells $78k in shares - Investing.com
Tarsus Pharma CMO Lin sells $78k in shares By Investing.com - Investing.com Australia
Azamian, Tarsus Pharmaceuticals CEO, sells $2.36m in stock By Investing.com - Investing.com Australia
Tarsus Pharma CCO Mottiwala sells $892k in shares By Investing.com - Investing.com Canada
Tarsus Pharma CCO Mottiwala sells $892k in shares - Investing.com
Tarsus Pharmaceuticals Insiders Sold Shares Worth Over $5.1M - TradingView
Tarsus (NASDAQ: TARS) HR chief sells 12,274 shares in tax-related trades - Stock Titan
Tarsus (NASDAQ: TARS) counsel sells shares to cover RSU tax - Stock Titan
Tarsus Pharmaceuticals (TARS) COO mandated sell-to-cover totals 11,324 shares - Stock Titan
Tax-driven stock sale by Tarsus (TARS) chief commercial officer - Stock Titan
Tarsus (NASDAQ: TARS) CMO sells shares to cover RSU tax withholding - Stock Titan
Tarsus (TARS) officer sells 6,430 shares in mandated tax sell-to-cover - Stock Titan
Tarsus Pharmaceuticals (TARS) CEO sells 34,603 shares to cover taxes - Stock Titan
TARS (NASDAQ: TARS) files notice to sell 2,186 shares via Fidelity - Stock Titan
TARS (NASDAQ: TARS) insider notifies sale of 4,440 shares via Fidelity - Stock Titan
TARS (NASDAQ: TARS) insider filings show proposed sale and recent dispositions - Stock Titan
Dianne Whitfield reports planned stock sales — TARS (NASDAQ: TARS) - Stock Titan
TARS (NASDAQ: TARS) insider sale notice; Bryan Wahl disposed of 8,209 shares - Stock Titan
TARS (NASDAQ: TARS) insider files Form 144 to resell 4,589 shares after vesting - Stock Titan
TARS (NASDAQ: TARS) insider files Rule 144 to offer 390 shares after vesting - Stock Titan
Q1 Earnings Estimate for TARS Issued By Lifesci Capital - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Insider Sell Alert: LINK WILLIAM J PHD Sells 12,500 Shares of Ta - GuruFocus
Tarsus Pharmaceuticals director Link sells $859k in stock By Investing.com - Investing.com India
Tarsus Pharmaceuticals director Link sells $859k in stock - Investing.com
Down 16.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Tarsus Pharmaceuticals (TARS) - MSN
William Phd Link Sells 12,500 Shares of Tarsus Pharmaceuticals (NASDAQ:TARS) Stock - MarketBeat
Dianne Whitfield notifies sale of 4,071 TARS shares (NASDAQ: TARS) - Stock Titan
Tarsus Pharmaceuticals Insider Sold Shares Worth $859,819, According to a Recent SEC Filing - marketscreener.com
Insider sale notice: Bryan Wahl to sell 4,125 shares (TARS) - Stock Titan
Bobak Azamian (TARS) files Rule 144 to sell 11,667 vested shares - Stock Titan
TARS (NASDAQ: TARS) reports insider sales and a 3,610-share vesting on Form 144 - Stock Titan
Aziz A. Mottiwala to sell 4,330 shares (NASDAQ: TARS) on 03/17/2026 - Stock Titan
Insider sale after RSU vesting — TARS (NASDAQ: TARS) files Form 144 - Stock Titan
Tarsus (TARS) director William J. Link sells 12,500 shares in planned trades - Stock Titan
Tarsus Pharmaceuticals, Inc. (TARS) reports Q4 loss, beats revenue estimates - MSN
What is Lifesci Capital's Forecast for TARS Q3 Earnings? - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Rating Increased to Strong-Buy at Lifesci Capital - MarketBeat
Tarsus (TARS) HR chief settles RSUs, holds 47,302 common shares - Stock Titan
Tarsus Pharmaceuticals (NASDAQ: TARS) general counsel exercises 24,236 RSUs - Stock Titan
Tarsus (NASDAQ: TARS) CCO receives 26,482 shares from RSUs - Stock Titan
Jeffrey Farrow of Tarsus (TARS) acquires 13,042 shares through RSU settlement - Stock Titan
Tarsus (TARS) CEO adds 66,274 shares via RSU settlement - Stock Titan
Tarsus (NASDAQ: TARS) CMO gains 2,511 shares in RSU settlement - Stock Titan
[144] Tarsus Pharmaceuticals, Inc. SEC Filing - Stock Titan
TARS (NASDAQ: TARS) insider files to sell 4,029 shares after vesting - Stock Titan
Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS) and Olema Pharmaceuticals (OLMA) - The Globe and Mail
TARS PE Ratio & Valuation, Is TARS Overvalued - Intellectia AI
TARS (NASDAQ: TARS) affiliate notifies sale of 2,133 vested shares - Stock Titan
Tarsus Pharmaceuticals (TARS) files Section 144 notice to sell 12,500 shares - Stock Titan
Sentiment Recap: Why is Tarsus Pharmaceuticals Inc stock going downShort Setup & Stock Portfolio Risk Management - baoquankhu1.vn
Tarsus Pharmaceuticals, Inc. $TARS Shares Sold by Capitolis Liquid Global Markets LLC - MarketBeat
Ally Bridge Group NY LLC Decreases Stake in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
COO at Tarsus (NASDAQ: TARS) gets 26,287 common shares from RSUs - Stock Titan
Integral Health Asset Management LLC Has $14.86 Million Stock Holdings in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals at Barclays Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals (NASDAQ:TARS) Trading Down 6.1%Should You Sell? - MarketBeat
Quantbot Technologies LP Reduces Holdings in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
(TARS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Tarsus Pharmaceuticals, Inc. $TARS Shares Sold by Jefferies Financial Group Inc. - MarketBeat
The Bull Case For Tarsus Pharmaceuticals (TARS) Could Change Following First 2026 XDEMVY Sales Outlook - Sahm
Tarsus Pharmaceuticals Bets Big on XDEMVY Growth - TipRanks
Stock option and RSU grants for Tarsus (NASDAQ: TARS) executive - Stock Titan
Tarsus (TARS) Chief Commercial Officer receives new option and RSU grants - Stock Titan
1.20%
0.06%
자본화:
|
볼륨(24시간):